Transcode Historical Cash Flow
| RNAZ Stock | USD 0.34 0.04 10.53% |
Analysis of Transcode Therapeutics cash flow over time is an excellent tool to project Transcode Therapeutics future capital expenditures as well as to predict the amount of cash needed to cover cost of sales, R&D expenses or production expansions. Investors should almost always look for trends in cash flow indicators such as End Period Cash Flow of 5.5 M or Change To Netincome of 764.7 K as it is a great indicator of Transcode Therapeutics ability to facilitate future growth, repay debt on time or pay out dividends.
Financial Statement Analysis is much more than just reviewing and examining Transcode Therapeutics latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Transcode Therapeutics is a good buy for the upcoming year.
Transcode |
About Transcode Cash Flow Analysis
The Cash Flow Statement is a financial statement that shows how changes in Transcode balance sheet and income statement accounts affect cash and cash equivalents. It breaks the analysis down to operating, investing, and financing activities. One of the most critical aspects of the cash flow statement is liquidity, which is the degree to which Transcode's non-liquid assets can be easily converted into cash.
Transcode Therapeutics Cash Flow Chart
Add Fundamental
Net Borrowings
The difference between the amount of new debt a company has taken on and the amount of debt it has paid off during a given period.Capital Expenditures
Capital Expenditures are funds used by Transcode Therapeutics to acquire physical assets such as property, industrial buildings or equipment. This type of outlay is used by management to increase the scope of Transcode Therapeutics operations. These expenditures can include everything from repairing an office equipment, building a brand new facility, or writing new software.Most accounts from Transcode Therapeutics' cash flow statement are interrelated and interconnected. However, analyzing cash flow statement accounts one by one will only give a small insight into Transcode Therapeutics current financial condition. On the other hand, looking into the entire matrix of cash flow statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Transcode Therapeutics. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in nation. For more information on how to buy Transcode Stock please use our How to Invest in Transcode Therapeutics guide.At this time, Transcode Therapeutics' End Period Cash Flow is fairly stable compared to the past year. Change To Liabilities is likely to rise to about 2.2 M in 2024, despite the fact that Change In Cash is likely to grow to (2.1 M).
| 2010 | 2022 | 2023 | 2024 (projected) | Capital Expenditures | 254.8K | 100.9K | 35.6K | 33.8K | Depreciation | 42.5K | 98.6K | 516.7K | 542.6K |
Transcode Therapeutics cash flow statement Correlations
Click cells to compare fundamentals
Transcode Therapeutics Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Transcode Therapeutics cash flow statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Change In Cash | (8.5K) | 623.5K | 20.0M | (15.9M) | (2.2M) | (2.1M) | |
| Other Cashflows From Financing Activities | 1M | (73.5K) | (818.6K) | 6.0K | (35.6K) | (33.8K) | |
| Total Cash From Operating Activities | (508.5K) | (493.0K) | (5.3M) | (15.8M) | (18.1M) | (17.2M) | |
| Net Income | (607.2K) | (2.3M) | (6.8M) | (17.6M) | (18.5M) | (17.6M) | |
| Total Cash From Financing Activities | 500K | 1.1M | 25.5M | 6.0K | 15.9M | 8.0M | |
| End Period Cash Flow | 204.5K | 828.0K | 20.8M | 5.0M | 2.8M | 5.5M | |
| Change To Liabilities | (54.7K) | 191.3K | 2.3M | 1.8M | 2.1M | 2.2M |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Transcode Stock Analysis
When running Transcode Therapeutics' price analysis, check to measure Transcode Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Transcode Therapeutics is operating at the current time. Most of Transcode Therapeutics' value examination focuses on studying past and present price action to predict the probability of Transcode Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Transcode Therapeutics' price. Additionally, you may evaluate how the addition of Transcode Therapeutics to your portfolios can decrease your overall portfolio volatility.